Skip to main content
$2.91 $0.01 (0.3%)

04:00 PM EST on 01/31/23

GlycoMemetics (NASDAQ:GLYC)

CAPS Rating: 3 out of 5

Current Price $2.91 Mkt Cap $152.0M
Open $2.87 P/E Ratio 0.00
Prev. Close $2.91 Div. (Yield) $0.00 (0.0%)
Daily Range $2.85 - $3.02 Volume 796,962
52-Wk Range $0.51 - $3.60 Avg. Daily Vol. 870,935

Caps

How do you think NASDAQ:GLYC will perform against the market?

Add Stock to CAPS Watchlist

All Players

39 Outperform
5 Underperform
 

All-Star Players

11 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GLYC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mrbill6 (59.95)
Submitted January 01, 2023

Investor Observer Top5

zzlangerhans (99.72)
Submitted March 31, 2015

I have a fairly straightforward problem with GlycoMimetics, which is that I think that their lead candidate rivipansel is dead and the share price has not declined to take this into account. Pfizer not initiated a phase III trial of rivipansel… More

NASDAQ:GLYC Summary

Recent Community Commentary

Read the most recent pitches from players about GLYC.

Recs

1
Member Avatar mrbill6 (59.95) Submitted: 1/1/2023 6:11:19 PM : Outperform Start Price: $2.09 NASDAQ:GLYC Score: +38.08

Investor Observer Top5

Recs

1
Member Avatar TMFEBCapital (81.42) Submitted: 12/18/2017 3:28:42 PM : Outperform Start Price: $16.37 NASDAQ:GLYC Score: -133.80

Potential to reshape relapsing and recurring AML, improving outcomes and tolerability of existing chemotherapy regimens.

Recs

1
Member Avatar manirg (< 20) Submitted: 12/2/2014 8:41:39 AM : Outperform Start Price: $8.45 NASDAQ:GLYC Score: -162.36

Undervalued

Leaderboard

Find the members with the highest scoring picks in GLYC.

Score Leader

drugtrader

drugtrader (66.42) Score: +230.13

The Score Leader is the player with the highest score across all their picks in GLYC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildShaman 75.49 7/9/2018 Underperform 5Y $16.93 -82.81% +46.98% +129.79 0 Comment
giftofgod < 20 8/13/2018 Underperform 1Y $14.46 -79.88% +43.39% +123.27 0 Comment
JohnnyCaffeine < 20 12/28/2021 Outperform 5Y $1.51 +92.72% -14.94% +107.66 0 Comment
eagles777 70.28 11/15/2022 Outperform 5Y $1.64 +77.54% +1.35% +76.19 0 Comment
DyingClub < 20 8/3/2020 Underperform 5Y $4.18 -30.38% +23.81% +54.19 0 Comment
mrbill6 59.95 11/25/2022 1/1/2023 Outperform 3M $2.09 +39.23% +1.16% +38.08 1 Comment
NorteClub 73.32 6/11/2020 Underperform 5Y $2.83 +2.83% +30.55% +27.73 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. drugtrader 66.42 6/14/2021 Outperform 5Y $2.68 +8.67% -3.99% +12.66 0 Comment
Under5 66.47 1/5/2023 Outperform 5Y $2.97 -2.02% +6.49% -8.51 0 Comment
foggs1 68.47 3/10/2021 Outperform 5Y $3.05 -4.59% +4.31% -8.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GLYC.